Amphastar Pharmaceuticals
AMPH
AMPH
111 hedge funds and large institutions have $356M invested in Amphastar Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $160K
Holders
111
Holding in Top 10
–
Calls
–
Puts
$160K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$2.05M | |
| 3 | +$1.29M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.28M |
| 5 |
BlackRock
New York
|
+$1.11M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$5.33M | |
| 3 | -$3.7M | |
| 4 |
MSL
Mackay Shields LLC
New York
|
-$3.46M |
| 5 |
MCM
Matarin Capital Management
New York
|
-$2.34M |